Dr. Ronan Kelly Q&A: FDA-Approved Cellular Therapy for Metastatic Melanoma Now Available at Baylor University Medical Center in Dallas
Ronan Kelly, MD, director of oncology, Baylor Scott & White Charles A. Sammons Cancer Center at Baylor University Medical Center at Dallas, explains how the new tumor-infiltrating lymphocytes (TIL) therapy is designed to better empower the immune system to fight cancer.